Ipilimumab (3 mg/kg) clinical trials

A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.

This study looks at giving a new cancer drug called ipilimumab to people with a type of brain cancer (glioblastoma) before their usual treatment. It aims to check if the drug is safe and if it helps control the cancer at this early stage.